title: Q&A: What have we found out about the influenza A (H1N1) 2009 pandemic virus?
authors.affiliation: Department of Microbiology and Immunology, The University of Melbourne, Parkville, Victoria, 3010, Australia. sjturn@unimelb.edu.au
authors.forename: Stephen J
authors.initials: SJ
authors.lastname: Turner
authors.forename: Lorena E
authors.initials: LE
authors.lastname: Brown
authors.forename: Peter C
authors.initials: PC
authors.lastname: Doherty
authors.forename: Anne
authors.initials: A
authors.lastname: Kelso
mesh_terms: D000818:Animals; D000998:Antiviral Agents / Q000627:therapeutic use; D004196:Disease Outbreaks; D024882:Drug Resistance, Viral; D006801:Humans; D007110:Immunity, Active; D053118:Influenza A Virus, H1N1 Subtype / Q000187:drug effects / Q000276:immunology* / Q000472:pathogenicity*; D007252:Influenza Vaccines / Q000627:therapeutic use; D007251:Influenza, Human / Q000453:epidemiology / Q000209:etiology* / Q000628:therapy; D053139:Oseltamivir / Q000627:therapeutic use; D013997:Time Factors; D014774:Virulence; D053243:Zanamivir / Q000627:therapeutic use
chemical_list: D000998:Antiviral Agents; D007252:Influenza Vaccines; D053139:Oseltamivir; D053243:Zanamivir